ACBRD develops and validates the novel “Glucose Monitoring Experiences Questionnaire (GME-Q)”, for use among adults with type 1 diabetes.
By Dr Elizabeth Holmes-Truscott
ACBRD develops and validates the novel “Glucose Monitoring Experiences Questionnaire (GME-Q)”, for use among adults with type 1 diabetes.
By Dr Elizabeth Holmes-Truscott
Secondary analysis of the HypoCOMPaSS trial highlights greater satisfaction with insulin pump than multiple daily injections
Researchers from King’s College London have explored the role of beliefs about low and high glucose levels in ~2000 adults with type 1 diabetes
Research from the US suggests no difference in diabetes-related distress among adults with type 1 diabetes with a free choice of insulin pumps versus multiple daily insulin injections.
It’s back to business as usual this week in the ACBRD office. However, we have taken time to reflect on last week’s Australasian Diabetes Congress (ADC: 21-23 Aug, Sydney). It was fantastic to hear so many of our esteemed colleagues, peers and friends share their inspiring research, work and lived experiences
Our latest findings from Diabetes MILES-2, published in Mindfulness, shows self-compassion is associated with a range of important diabetes outcomes
Using data from the MILES-2 study, we have validated the DAWN Impact of Diabetes Profile
A qualitative study (from researchers at Kings College London) explores how adults with newly diagnosed type 1 diabetes experience and adapt to this new reality